Požymis
Repeated seizures without recovery between them
Klinikinis pavadinimas: Status epilepticus
Status epilepticus is a type of prolonged seizure resulting either from the failure of the mechanisms responsible for seizure termination or from the initiation of mechanisms which lead to abnormally prolonged seizures (after time point t1). It is a condition that can have long-term consequences (after time point t2), including neuronal death, neuronal injury, and alteration of neuronal networks, depending on the type and duration of seizures.
Santrauka
- Taip pat vadinama
- Prolonged seizure, Repeated seizure without recovery
- Kūno sistema
- Abnormality of the nervous system
Ši puslapis kaip duomenys
Norėdami perskaityti jį kaip JSON, pridėkite .json prie puslapio adreso arba nurodykite application/json.
library(jsonlite)
url <- "https://dantelabs.com/traits/status-epilepticus.json"
page <- fromJSON(url)
page$trait$nameVienu tyrimu sužinokite genus, susijusius su Repeated seizures without recovery between them, ir kitą jūsų genomo dalį.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites
Įsigyti savo Genome Test207 genų susiję su Repeated seizures without recovery between them
Šių genų pakitimai sukelia retas ligas, kuriose pasireiškia Repeated seizures without recovery between them. Dauguma žmonių, turinčių šį požymį, neturi nė vienos iš tų ligų, o šiame sąraše esantis genas nieko nesako apie kieno nors paties genomą.
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| AGO1argonaute RISC component 1 | Visada | 1 ligoje |
| APTXaprataxin | Visada | 1 ligoje |
| ARV1ARV1 fatty acid homeostasis modulator | Visada | 1 ligoje |
| BCL10BCL10 immune signaling adaptor | Visada | 1 ligoje |
| CARS2cysteinyl-tRNA synthetase 2, mitochondrial | Visada | 2 ligose |
| CCDC88Acoiled-coil and HOOK domain protein 88A | Visada | 1 ligoje |
| COG8component of oligomeric golgi complex 8 | Visada | 1 ligoje |
| COQ2coenzyme Q2, polyprenyltransferase | Visada | 1 ligoje |
| COX10cytochrome c oxidase assembly factor heme A:farnesyltransferase COX10 | Visada | 1 ligoje |
| DHDDSdehydrodolichyl diphosphate synthase subunit | Visada | 2 ligose |
| DNM1Ldynamin 1L | Visada | 2 ligose |
| ECE1endothelin converting enzyme 1 | Visada | 1 ligoje |
| FDXRferredoxin reductase | Visada | 1 ligoje |
| GET4guided entry of tail-anchored proteins factor 4 | Visada | 1 ligoje |
| GRIN2Bglutamate ionotropic receptor NMDA type subunit 2B | Visada | 1 ligoje |
| JKAMPJNK1/MAPK8 associated membrane protein | Visada | 1 ligoje |
| KLHL20kelch like family member 20 | Visada | 1 ligoje |
| MECP2methyl-CpG binding protein 2 | Visada | 1 ligoje |
| MICU1mitochondrial calcium uptake 1 | Visada | 1 ligoje |
| MRM2mitochondrial rRNA methyltransferase 2 | Visada | 1 ligoje |
| NFU1NFU1 iron-sulfur cluster scaffold | Visada | 1 ligoje |
| NOTCH3notch receptor 3 | Visada | 1 ligoje |
| NUS1NUS1 dehydrodolichyl diphosphate synthase subunit | Visada | 2 ligose |
| PIGAphosphatidylinositol glycan anchor biosynthesis class A | Visada | 2 ligose |
| PSAPprosaposin | Visada | 1 ligoje |
| RFC4replication factor C subunit 4 | Visada | 1 ligoje |
| SCN2Asodium voltage-gated channel alpha subunit 2 | Visada | 5 ligose |
| TANGO2transport and golgi organization 2 homolog | Visada | 1 ligoje |
| TMEM63Btransmembrane protein 63B | Visada | 1 ligoje |
| TRAPPC2Ltrafficking protein particle complex subunit 2L | Visada | 1 ligoje |
| TWNKtwinkle mtDNA helicase | Visada | 1 ligoje |
| UGGT1UDP-glucose glycoprotein glucosyltransferase 1 | Visada | 1 ligoje |
| UQCC2ubiquinol-cytochrome c reductase complex assembly factor 2 | Visada | 1 ligoje |
| VPS51VPS51 subunit of GARP complex | Visada | 1 ligoje |
| WWOXWW domain containing oxidoreductase | Visada | 1 ligoje |
| ARXaristaless related homeobox | Labai dažnai (80–99%) | 1 ligoje |
| GABRA1gamma-aminobutyric acid type A receptor subunit alpha1 | Labai dažnai (80–99%) | 2 ligose |
| LGI1leucine rich glioma inactivated 1 | Labai dažnai (80–99%) | 1 ligoje |
| PIGSphosphatidylinositol glycan anchor biosynthesis class S | Labai dažnai (80–99%) | 1 ligoje |
| PNPOpyridoxamine 5'-phosphate oxidase | Labai dažnai (80–99%) | 1 ligoje |
Rodyti dar 167 genų
| Genas | Kaip dažnai pasireiškia | Ligos |
|---|---|---|
| RNU4ATACRNA, U4atac small nuclear | Labai dažnai (80–99%) | 2 ligose |
| SLC13A5solute carrier family 13 member 5 | Labai dažnai (80–99%) | 2 ligose |
| SLC2A1solute carrier family 2 member 1 | Labai dažnai (80–99%) | 2 ligose |
| TIMM50translocase of inner mitochondrial membrane 50 | Labai dažnai (80–99%) | 1 ligoje |
| ALDH5A1aldehyde dehydrogenase 5 family member A1 | Dažnai (30–79%) | 2 ligose |
| ALDH7A1aldehyde dehydrogenase 7 family member A1 | Dažnai (30–79%) | 2 ligose |
| AP3B2adaptor related protein complex 3 subunit beta 2 | Dažnai (30–79%) | 2 ligose |
| AQP4aquaporin 4 | Dažnai (30–79%) | 2 ligose |
| ATP1A1ATPase Na+/K+ transporting subunit alpha 1 | Dažnai (30–79%) | 2 ligose |
| ATP1A3ATPase Na+/K+ transporting subunit alpha 3 | Dažnai (30–79%) | 4 ligose |
| ATP6V0A2ATPase H+ transporting V0 subunit a2 | Dažnai (30–79%) | 1 ligoje |
| CADcarbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase | Dažnai (30–79%) | 1 ligoje |
| CHD2chromodomain helicase DNA binding protein 2 | Dažnai (30–79%) | 1 ligoje |
| CNTNAP2contactin associated protein 2 | Dažnai (30–79%) | 1 ligoje |
| CRELD1CRELD disulfide isomerase 1 | Dažnai (30–79%) | 1 ligoje |
| DEAF1DEAF1 transcription factor | Dažnai (30–79%) | 2 ligose |
| DHCR2424-dehydrocholesterol reductase | Dažnai (30–79%) | 1 ligoje |
| DTYMKdeoxythymidylate kinase | Dažnai (30–79%) | 1 ligoje |
| EHMT1euchromatic histone lysine methyltransferase 1 | Dažnai (30–79%) | 1 ligoje |
| EPM2AEPM2A glucan phosphatase, laforin | Dažnai (30–79%) | 1 ligoje |
| FGF12fibroblast growth factor 12 | Dažnai (30–79%) | 2 ligose |
| FIG4FIG4 phosphoinositide 5-phosphatase | Dažnai (30–79%) | 1 ligoje |
| GABRA2gamma-aminobutyric acid type A receptor subunit alpha2 | Dažnai (30–79%) | 2 ligose |
| GABRA5gamma-aminobutyric acid type A receptor subunit alpha5 | Dažnai (30–79%) | 2 ligose |
| GLYCTKglycerate kinase | Dažnai (30–79%) | 1 ligoje |
| GRM7glutamate metabotropic receptor 7 | Dažnai (30–79%) | 1 ligoje |
| HCN1hyperpolarization activated cyclic nucleotide gated potassium channel 1 | Dažnai (30–79%) | 3 ligose |
| IFNGinterferon gamma | Dažnai (30–79%) | 1 ligoje |
| IQSEC1IQ motif and Sec7 domain ArfGEF 1 | Dažnai (30–79%) | 1 ligoje |
| LMNB2lamin B2 | Dažnai (30–79%) | 1 ligoje |
| MDGA2MAM domain containing glycosylphosphatidylinositol anchor 2 | Dažnai (30–79%) | 2 ligose |
| NDUFA6NADH:ubiquinone oxidoreductase subunit A6 | Dažnai (30–79%) | 1 ligoje |
| NDUFA8NADH:ubiquinone oxidoreductase subunit A8 | Dažnai (30–79%) | 1 ligoje |
| NHLRC1NHL repeat containing E3 ubiquitin protein ligase 1 | Dažnai (30–79%) | 1 ligoje |
| NTRK2neurotrophic receptor tyrosine kinase 2 | Dažnai (30–79%) | 2 ligose |
| PCDH19protocadherin 19 | Dažnai (30–79%) | 2 ligose |
| PLPBPpyridoxal phosphate binding protein | Dažnai (30–79%) | 1 ligoje |
| POLGDNA polymerase gamma, catalytic subunit | Dažnai (30–79%) | 1 ligoje |
| PPP2R5Cprotein phosphatase 2 regulatory subunit B'gamma | Dažnai (30–79%) | 1 ligoje |
| PUM1pumilio RNA binding family member 1 | Dažnai (30–79%) | 1 ligoje |
| RHOBTB2Rho related BTB domain containing 2 | Dažnai (30–79%) | 2 ligose |
| RNU2-2RNA, U2 small nuclear 2 | Dažnai (30–79%) | 1 ligoje |
| SLC25A12solute carrier family 25 member 12 | Dažnai (30–79%) | 1 ligoje |
| SMARCA2SWI/SNF related BAF chromatin remodeling complex subunit ATPase 2 | Dažnai (30–79%) | 1 ligoje |
| TBC1D24TBC1 domain family member 24 | Dažnai (30–79%) | 2 ligose |
| TSC1TSC complex subunit 1 | Dažnai (30–79%) | 1 ligoje |
| TSC2TSC complex subunit 2 | Dažnai (30–79%) | 1 ligoje |
| UNC13Aunc-13 homolog A | Dažnai (30–79%) | 1 ligoje |
| VARS1valyl-tRNA synthetase 1 | Dažnai (30–79%) | 1 ligoje |
| WDR4WDR4 tRNA N7-guanosine methyltransferase non-catalytic subunit | Dažnai (30–79%) | 1 ligoje |
| ABCC8ATP binding cassette subfamily C member 8 | Kartais (5–29%) | 1 ligoje |
| AKT3AKT serine/threonine kinase 3 | Kartais (5–29%) | 1 ligoje |
| ALDH4A1aldehyde dehydrogenase 4 family member A1 | Kartais (5–29%) | 1 ligoje |
| ATP1A2ATPase Na+/K+ transporting subunit alpha 2 | Kartais (5–29%) | 3 ligose |
| ATXN10ataxin 10 | Kartais (5–29%) | 1 ligoje |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Kartais (5–29%) | 3 ligose |
| CACNA1Ecalcium voltage-gated channel subunit alpha1 E | Kartais (5–29%) | 1 ligoje |
| CARS1cysteinyl-tRNA synthetase 1 | Kartais (5–29%) | 1 ligoje |
| COX7Bcytochrome c oxidase subunit 7B | Kartais (5–29%) | 1 ligoje |
| DIS3L2DIS3 like 3'-5' exoribonuclease 2 | Kartais (5–29%) | 1 ligoje |
| EEFSECeukaryotic elongation factor, selenocysteine-tRNA specific | Kartais (5–29%) | 1 ligoje |
| EFHC1EF-hand domain containing 1 | Kartais (5–29%) | 3 ligose |
| ELFN1extracellular leucine rich repeat and fibronectin type III domain containing 1 | Kartais (5–29%) | 1 ligoje |
| GNB1G protein subunit beta 1 | Kartais (5–29%) | 1 ligoje |
| GPRC5BG protein-coupled receptor class C group 5 member B | Kartais (5–29%) | 1 ligoje |
| GRIA3glutamate ionotropic receptor AMPA type subunit 3 | Kartais (5–29%) | 1 ligoje |
| GRIA4glutamate ionotropic receptor AMPA type subunit 4 | Kartais (5–29%) | 1 ligoje |
| GRIN1glutamate ionotropic receptor NMDA type subunit 1 | Kartais (5–29%) | 1 ligoje |
| HCCSholocytochrome c synthase | Kartais (5–29%) | 1 ligoje |
| HEPACAMhepatic and glial cell adhesion molecule | Kartais (5–29%) | 1 ligoje |
| KCNH5potassium voltage-gated channel subfamily H member 5 | Kartais (5–29%) | 2 ligose |
| KCNJ11potassium inwardly rectifying channel subfamily J member 11 | Kartais (5–29%) | 1 ligoje |
| KCNMA1potassium calcium-activated channel subfamily M alpha 1 | Kartais (5–29%) | 1 ligoje |
| KCNT1potassium sodium-activated channel subfamily T member 1 | Kartais (5–29%) | 2 ligose |
| KIF11kinesin family member 11 | Kartais (5–29%) | 1 ligoje |
| MLC1modulator of VRAC current 1 | Kartais (5–29%) | 1 ligoje |
| MT-TL2mitochondrially encoded tRNA-Leu (CUN) 2 | Kartais (5–29%) | 1 ligoje |
| MTORmechanistic target of rapamycin kinase | Kartais (5–29%) | 1 ligoje |
| NDUFB11NADH:ubiquinone oxidoreductase subunit B11 | Kartais (5–29%) | 1 ligoje |
| PACS2phosphofurin acidic cluster sorting protein 2 | Kartais (5–29%) | 2 ligose |
| PET100PET100 cytochrome c oxidase chaperone | Kartais (5–29%) | 1 ligoje |
| PGM2L1phosphoglucomutase 2 like 1 | Kartais (5–29%) | 1 ligoje |
| PIK3CAphosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | Kartais (5–29%) | 1 ligoje |
| PPP3CAprotein phosphatase 3 catalytic subunit alpha | Kartais (5–29%) | 2 ligose |
| QARS1glutaminyl-tRNA synthetase 1 | Kartais (5–29%) | 1 ligoje |
| RRM2Bribonucleotide reductase regulatory TP53 inducible subunit M2B | Kartais (5–29%) | 1 ligoje |
| SATB1SATB homeobox 1 | Kartais (5–29%) | 1 ligoje |
| SLC19A3solute carrier family 19 member 3 | Kartais (5–29%) | 1 ligoje |
| SLC1A3solute carrier family 1 member 3 | Kartais (5–29%) | 1 ligoje |
| SLC32A1solute carrier family 32 member 1 | Kartais (5–29%) | 2 ligose |
| SMARCAL1SNF2 related chromatin remodeling annealing helicase 1 | Kartais (5–29%) | 1 ligoje |
| SONSON DNA and RNA binding protein | Kartais (5–29%) | 1 ligoje |
| STRADASTE20 related adaptor alpha | Kartais (5–29%) | 1 ligoje |
| SVBPsmall vasohibin binding protein | Kartais (5–29%) | 1 ligoje |
| TBC1D20TBC1 domain family member 20 | Kartais (5–29%) | 1 ligoje |
| TBK1TANK binding kinase 1 | Kartais (5–29%) | 2 ligose |
| TICAM1TIR domain containing adaptor molecule 1 | Kartais (5–29%) | 1 ligoje |
| TLR3toll like receptor 3 | Kartais (5–29%) | 1 ligoje |
| TRAF3TNF receptor associated factor 3 | Kartais (5–29%) | 1 ligoje |
| UCP2uncoupling protein 2 | Kartais (5–29%) | 1 ligoje |
| UNC93B1unc-93B1 regulator of TLR signaling | Kartais (5–29%) | 1 ligoje |
| UPB1beta-ureidopropionase 1 | Kartais (5–29%) | 1 ligoje |
| YWHAGtyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein gamma | Kartais (5–29%) | 2 ligose |
| AARS1alanyl-tRNA synthetase 1 | Retai (1–4 %) | 1 ligoje |
| ACTL6Bactin like 6B | Retai (1–4 %) | 1 ligoje |
| ADGRV1adhesion G protein-coupled receptor V1 | Retai (1–4 %) | 1 ligoje |
| ATP6V1AATPase H+ transporting V1 subunit A | Retai (1–4 %) | 1 ligoje |
| BSCL2BSCL2 lipid droplet biogenesis associated, seipin | Retai (1–4 %) | 1 ligoje |
| CACNA1Bcalcium voltage-gated channel subunit alpha1 B | Retai (1–4 %) | 1 ligoje |
| CACNA2D1calcium voltage-gated channel auxiliary subunit alpha2delta 1 | Retai (1–4 %) | 1 ligoje |
| CACNB4calcium voltage-gated channel auxiliary subunit beta 4 | Retai (1–4 %) | 1 ligoje |
| CDK19cyclin dependent kinase 19 | Retai (1–4 %) | 1 ligoje |
| CELF2CUGBP Elav-like family member 2 | Retai (1–4 %) | 1 ligoje |
| CILK1ciliogenesis associated kinase 1 | Retai (1–4 %) | 1 ligoje |
| CLCN2chloride voltage-gated channel 2 | Retai (1–4 %) | 1 ligoje |
| CLTCclathrin heavy chain | Retai (1–4 %) | 1 ligoje |
| CNKSR2connector enhancer of kinase suppressor of Ras 2 | Retai (1–4 %) | 1 ligoje |
| CPA6carboxypeptidase A6 | Retai (1–4 %) | 1 ligoje |
| CYFIP2cytoplasmic FMR1 interacting protein 2 | Retai (1–4 %) | 1 ligoje |
| DALRD3DALR anticodon binding domain containing 3 | Retai (1–4 %) | 1 ligoje |
| DEPDC5DEP domain containing 5, GATOR1 subcomplex subunit | Retai (1–4 %) | 1 ligoje |
| DNM1dynamin 1 | Retai (1–4 %) | 1 ligoje |
| EEF1A2eukaryotic translation elongation factor 1 alpha 2 | Retai (1–4 %) | 1 ligoje |
| FBXO28F-box protein 28 | Retai (1–4 %) | 1 ligoje |
| FGF13fibroblast growth factor 13 | Retai (1–4 %) | 1 ligoje |
| FOXG1forkhead box G1 | Retai (1–4 %) | 1 ligoje |
| FZR1fizzy and cell division cycle 20 related 1 | Retai (1–4 %) | 1 ligoje |
| GABBR2gamma-aminobutyric acid type B receptor subunit 2 | Retai (1–4 %) | 1 ligoje |
| GABRB2gamma-aminobutyric acid type A receptor subunit beta2 | Retai (1–4 %) | 1 ligoje |
| GABRDgamma-aminobutyric acid type A receptor subunit delta | Retai (1–4 %) | 2 ligose |
| GABRG2gamma-aminobutyric acid type A receptor subunit gamma2 | Retai (1–4 %) | 2 ligose |
| GPAA1glycosylphosphatidylinositol anchor attachment 1 | Retai (1–4 %) | 1 ligoje |
| GRIN2Dglutamate ionotropic receptor NMDA type subunit 2D | Retai (1–4 %) | 1 ligoje |
| IARS2isoleucyl-tRNA synthetase 2, mitochondrial | Retai (1–4 %) | 1 ligoje |
| JRKJrk helix-turn-helix protein | Retai (1–4 %) | 1 ligoje |
| KCNA2potassium voltage-gated channel subfamily A member 2 | Retai (1–4 %) | 1 ligoje |
| KCNB1potassium voltage-gated channel subfamily B member 1 | Retai (1–4 %) | 1 ligoje |
| KCNC2potassium voltage-gated channel subfamily C member 2 | Retai (1–4 %) | 1 ligoje |
| KCNQ2potassium voltage-gated channel subfamily Q member 2 | Retai (1–4 %) | 2 ligose |
| KCNQ3potassium voltage-gated channel subfamily Q member 3 | Retai (1–4 %) | 3 ligose |
| NECAP1NECAP endocytosis associated 1 | Retai (1–4 %) | 1 ligoje |
| PARS2prolyl-tRNA synthetase 2, mitochondrial | Retai (1–4 %) | 1 ligoje |
| PRRT2proline rich transmembrane protein 2 | Retai (1–4 %) | 3 ligose |
| SCN1Asodium voltage-gated channel alpha subunit 1 | Retai (1–4 %) | 4 ligose |
| SCN1Bsodium voltage-gated channel beta subunit 1 | Retai (1–4 %) | 1 ligoje |
| SCN3Asodium voltage-gated channel alpha subunit 3 | Retai (1–4 %) | 1 ligoje |
| SCN8Asodium voltage-gated channel alpha subunit 8 | Retai (1–4 %) | 2 ligose |
| SCN9Asodium voltage-gated channel alpha subunit 9 | Retai (1–4 %) | 1 ligoje |
| SLC1A2solute carrier family 1 member 2 | Retai (1–4 %) | 1 ligoje |
| SLC38A3solute carrier family 38 member 3 | Retai (1–4 %) | 1 ligoje |
| STX1Bsyntaxin 1B | Retai (1–4 %) | 1 ligoje |
| SYNGAP1synaptic Ras GTPase activating protein 1 | Retai (1–4 %) | 1 ligoje |
| SYNJ1synaptojanin 1 | Retai (1–4 %) | 1 ligoje |
| SZT2SZT2 subunit of KICSTOR complex | Retai (1–4 %) | 1 ligoje |
| TRAK1trafficking kinesin protein 1 | Retai (1–4 %) | 2 ligose |
| UBA5ubiquitin like modifier activating enzyme 5 | Retai (1–4 %) | 1 ligoje |
| UFSP2UFM1 specific peptidase 2 | Retai (1–4 %) | 1 ligoje |
| AMACRalpha-methylacyl-CoA racemase | Neužfiksuota | 1 ligoje |
| CTSDcathepsin D | Neužfiksuota | 1 ligoje |
| FHfumarate hydratase | Neužfiksuota | 1 ligoje |
| ITPAinosine triphosphatase | Neužfiksuota | 1 ligoje |
| NARS2asparaginyl-tRNA synthetase 2, mitochondrial | Neužfiksuota | 1 ligoje |
| NEXMIFneurite extension and migration factor | Neužfiksuota | 1 ligoje |
| PRODHproline dehydrogenase 1 | Neužfiksuota | 1 ligoje |
| SLC12A5solute carrier family 12 member 5 | Neužfiksuota | 1 ligoje |
| ST3GAL5ST3 beta-galactoside alpha-2,3-sialyltransferase 5 | Neužfiksuota | 1 ligoje |
| STXBP1syntaxin binding protein 1 | Neužfiksuota | 1 ligoje |
Kaip dažnai šis požymis pasitaiko žmonėms, turintiems vieną iš geno sukeliamų ligų, ir kuris dažnis tarp jų didžiausias, pagal Žmogaus fenotipo ontologijos duomenis. Šiuose puslapiuose aprašomi požymiai ir juos grindžiantys tyrimai; tai nėra diagnozė, o su simptomais kreipkitės į gydytoją ar genetikos konsultantą.
Siauresni požymiai
Platesni požymiai
Iš kur tai žinoma
- Žmogaus fenotipo ontologija, 2026-09-01 leidimas: požymis, jo pavadinimai, apibrėžimas ir su juo susiję genai. Daugiau sužinokite svetainėje hpo.jax.org.
- Duomenų leidimas 2026.10.17-8666dff2.
Vienas testas. Atsakymai visam gyvenimui.
Nuo 449 $Nemokamas pristatymas · Rezultatai per 6–8 savaites